Pulse Oximeter Market Size, Shares & Growth Opportunities 2025

Pulse Oximeter Market Size (2024–2034)

1 Current Market Size

◉The global pulse oximeter market is valued at USD 3.56 billion in 2024.

◉It is expected to grow to USD 3.8 billion in 2025.

2 Future Projections

◉By 2034, the market is projected to reach approximately USD 6.76 billion.

◉This represents a compound annual growth rate (CAGR) of 6.64% between 2025 and 2034.

Market Trends

1 Rising Disease Burden Driving Demand

◉Cardiovascular diseases affect >500 million people globally, causing 20.5 million deaths annually (~⅓ of global mortality).

◉Pulse oximeters are critical in managing heart failure (1.9–2.8% prevalence in U.S. adults) and respiratory disorders.

2 Technological Advancements

◉Wireless connectivity, smartphone integration, and improved accuracy & portability make devices more user-friendly.

◉Increasing use of wearable sensors enhances continuous monitoring and integration with digital platforms.

3 Remote Patient Monitoring & Digital Health

◉Masimo & Medable (May 2024): Integrated MightySat Rx into 8 pharma clinical trials across 25 countries (breast & lung cancer).

◉Nonin & Medixine (Apr 2024): Collaboration for remote monitoring of chronic conditions in the U.S.

Shifting Usage Pattern

◉Historically dominated by hospital bedside/tabletop use, but now moving rapidly toward homecare and portable devices.

◉Fitness and wellness adoption also boosting consumer-level demand.

4 Trade & Supply Chain Dynamics

From Oct 2023 – Sept 2024:

◉China: 9,251 oximeter shipments (top exporter, mainly to India, Chile, Peru).

◉U.S.: 5,417 shipments.

◉India: 998 shipments.

◉Asia’s manufacturing strength, especially China, continues to influence global pricing & supply availability.

5 Demographic & Healthcare Drivers

◉Aging population → higher incidence of cardiovascular & respiratory diseases.

◉Expanding healthcare infrastructure in emerging economies creating new opportunities.

◉Health awareness & self-monitoring among younger demographics driving portable oximeter sales.

AI’s Role in the Pulse Oximeter Market

A. Core Functional Impact

1 Real-time pattern detection

◉Processes SpO₂ and pulse rate in real time.

◉Spots early indicators of respiratory or cardiac issues.

2 Personalized monitoring

◉Learns individual baselines.

◉Delivers accurate, customized alerts (reduces generic false alarms).

3 Remote patient monitoring (RPM) automation

◉Automatically notifies providers about critical changes.

◉Improves proactive care in home/telemedicine workflows.

Predictive assistance

◉Forecasts potential complications.

◉Enables early intervention in chronic conditions (e.g., COPD).

4 Ecosystem integration

◉Works with other wearables and health apps to form a more complete profile.

5 Clinical decision support

◉Aids clinicians to act faster with more informed decisions and optimized care.

Market Dynamics

1 Driver

Rising incidence of respiratory diseases

◉COPD, asthma, pneumonia require regular SpO₂ monitoring.

◉Non-invasive, real-time measurements underpin adoption across hospitals, clinics, and home care.

◉Early detection of low oxygen levels improves condition management, driving growth.

2 Restraint

Government regulations

◉FDA and other regulators require extensive testing, certification, safety evaluation.

◉Varying regional rules complicate global manufacturing/distribution and add cost/time.

3 Opportunity

Remote patient monitoring & telemedicine

◉Continuous home-based monitoring for asthma, COPD, heart failure, including remote/underserved areas.

◉Mobile/wearable integrations enable real-time data sharing and timely intervention.

◉Growing consumer awareness and adoption of wearables expands clinical and home use.

Regional Insights

1 North America — Dominant (2024)

Drivers

◉High prevalence of COPD and sleep apnea requiring continuous monitoring.

◉Well-developed healthcare infrastructure; early tech adoption.

◉Growing geriatric population.

◉Ongoing advances in sensor accuracy and digital health integration.

U.S. trends

◉Chronic respiratory conditions + mobile/app integration + telehealth growth.

◉March 2024: Movano Health (with UCSF) completed hypoxia trial; Evie Ring pulse oximeter exceeded FDA accuracy guidelines.

Canada trends

◉Technological innovation (wireless, smartphone, cloud).

◉Supportive government regulation (device reliability/safety).

◉Public awareness boosting early detection and home/clinical use.

2 Asia-Pacific — Highest CAGR (forecast)

Growth factors

◉Large and aging population.

◉Rising respiratory and cardiovascular disease prevalence and health awareness.

◉Telemedicine investment and home-care expansion.

◉Rising disposable income and government early-detection initiatives.

China

◉Large aging cohort; chronic diseases (COPD/asthma/cardiovascular).

◉Government investment in modernizing infrastructure, including rural areas.

◉Telemedicine + home healthcare + public awareness lifting portable adoption.

India

◉Digital health and self-monitoring focus among a tech-savvy population.

◉Start-up ecosystem and Make in India boosting local, affordable, tailored devices.

◉Expansion of private healthcare and diagnostics strengthens demand.

3 Europe — Fast growth (forecast)

Drivers

◉Personalized/preventive healthcare shift.

◉Wearable/connected health demand and telehealth integration.

◉Strict standards → high-quality, accurate devices → strong consumer confidence.

◉Rising healthcare spend and broader reimbursement.

UK

◉Rising COPD, sleep apnea, heart disease.

◉Government action on racial/ethnic device disparities lifted trust and demand.

◉Home care/RPM with smartphone/wearable integrations gaining traction.

Germany

◉Strong infrastructure, high health spending, large aging population.

◉Chronic disease prevalence.

◉Preventive healthcare emphasis and data-tracking integration appealing to consumers/providers.

Top Companies 2025

1) Smiths Group plc

Product: MiniCorr Handheld Pulse Oximeters – designed for accurate SpO₂ and pulse rate monitoring.

Overview: A British multinational with a diversified medical technology portfolio. Focuses on delivering advanced patient monitoring systems globally.

Strengths:

Strong international presence.

Continuous innovation in handheld monitoring devices.

Solid financials: Revenue of £3.12 billion in FY 2024 (ended July 31, 2024), marking a 3.1% YoY increase.

2) Nihon Kohden Corporation

Product: Broad range of medical electronics including pulse oximeters integrated into hospital monitoring systems.

Overview: Japanese leader in medical electronics, known for advanced monitoring solutions and reliability.

Strengths:

Focus on innovation and precision in patient monitoring.

Trusted global brand in hospital-grade electronics.

Strong financial performance: ¥225,424 million net sales in FY 2025 (+1.5% YoY).

3) Koninklijke Philips N.V.

Product: Advanced patient monitoring platforms with integrated SpO₂ monitoring. Recent collaboration with Masimo expanded wearable monitoring.

Overview: A global healthcare technology giant with deep expertise in imaging, monitoring, and connected care.

Strengths:

Integration capabilities across hospital systems and telehealth.

Strong partnerships: In Jan 2023, partnered with Masimo to integrate the Masimo W1 health watch into Philips’ systems.

Leadership in remote patient monitoring (RPM) and digital health solutions.

4) Masimo Corporation

Product: Pulse oximeters using Signal Extraction Technology (SET®) – maintains accuracy during patient movement or low blood flow.

Overview: U.S.-based company specializing in advanced monitoring solutions. Known for setting benchmarks in pulse oximetry accuracy.

Strengths:

Best-in-class SpO₂ accuracy under challenging conditions.

Strong partnerships: In Nov 2023, teamed with GE Healthcare to integrate SET with GE’s Portrait Mobile wireless monitoring.

Reputation for continuous R&D and advanced patient monitoring solutions.

5) Medtronic plc

Product: Hospital-grade patient monitoring devices, including integrated pulse oximeters for ICUs and surgical care.

Overview: One of the world’s largest medical device companies, offering a broad portfolio across cardiovascular, surgical, and monitoring devices.

Strengths:

Large-scale hospital penetration.

Trusted brand for critical-care monitoring solutions.

Strong focus on innovation across global healthcare markets.

6) General Electric Company (GE Healthcare)

Product: Advanced hospital monitoring systems with integrated SpO₂ modules.

Overview: A healthcare division of GE, specializing in diagnostic and monitoring technologies.

Strengths:

Strong hospital networks worldwide.

Partnership with Masimo (2023) boosted capabilities in continuous wireless SpO₂ monitoring.

Known for high-reliability clinical solutions in ICUs and surgical settings.

7) Santa Medical

Product: SM-1100 Silver Finger Pulse Oximeter, Generation 2 (launched July 2024).

Overview: Manufacturer of consumer-friendly medical devices, targeting home healthcare.

Strengths:

Focus on portable, user-friendly oximeters.

Product highlights: Premium OLED display, strong battery life.

Appeals to preventive care and home-based monitoring markets.

8) Prevounce Health

Product: Pylo OX1-LTE (launched Aug 2024) – a connected blood oxygen device for Remote Patient Monitoring (RPM).

Overview: U.S.-based company focused on remote patient monitoring solutions for chronic disease management.

Strengths:

Device designed for simplicity and patient ease of use.

Boosts RPM engagement and reduces clinician workload.

Well-positioned in COPD, asthma, COVID-19, and heart condition monitoring.

9) Movano Health

Product: Evie Ring pulse oximeter (trial completed March 2024).

Overview: A health-tech company focusing on wearable health monitoring.

Strengths:

Conducted hypoxia trial with UCSF proving Evie Ring exceeded FDA accuracy guidelines.

Strong academic collaboration supporting product credibility.

Positioned in women’s health and consumer wearables with medical-grade accuracy.

10) BRAEBON

Product: MediOX (launched May 2025) – pulse oximeter with a chest-based body position sensor.

Overview: Innovator in sleep and respiratory monitoring solutions.

Strengths:

Device targets sleep-breathing disorder screening.

Multi-parameter tracking: SpO₂, pulse rate, body position.

Expands oximetry beyond respiratory into sleep medicine applications.